Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129083) titled 'Clinical Application Effect of Ciprofol Combined with Remifentanil in Painless Ultrasonic Gastroscopy' on July 30.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Nanjing Medical University
Condition:
Painless Ultrasonic Gastroscopy Examination
Intervention:
Observation group:For preemptive analgesia, low-concentration remifentanil (Yichang Humanwell Pharmaceutical Co., Ltd., NMPA Approval No. H20030197) at a dose of 0.3 µg/kg is administered intravenously slowly over no less than 30 seconds. Subsequently, cyclopropofol injection (Haisco Pharmac...